Salute e Benessere

IMG Appoints Justin Poehler as Chief Commercial Officer

"During my time at IMG, I've worked closely with the executive team to drive growth and position the company as a leader in the industry," said Poehler. "I am eager to expand my responsibilities as Chief Commercial Officer." "During my time at IMG, I've worked closely with the executive team to drive growth and position the company as a leader in the industry," said Poehler. "I am eager to expand my responsibilities as Chief Commercial Officer." Justin…
PR Newswire
23/08/2023

Mallinckrodt plc Enters into Restructuring Support Agreement with Key…

Intends to Initiate Voluntary Prepackaged Chapter 11 Proceedings to Implement Plan Intends to Initiate Voluntary Prepackaged Chapter 11 Proceedings to Implement Plan Continuing to Deliver High-Quality Therapies to Patients and Serve Customers; Vendors and Suppliers to be Paid in Full in the Ordinary Course DUBLIN,Aug. 23, 2023/PRNewswire/ --Mallinckrodtplc (NYSE American: MNK) (" Mallinckrodt " or the "Company"), a global specialty pharmaceutical company, today announced...
PR Newswire
23/08/2023

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer…

Dr. Denlinger has a long history of global cancer care leadership with NCCN and beyond. She was named an NCCN Young Investigator Awardee in 2012 and received the NCCN Rodger Winn Award in 2018 for exemplifying leadership, drive, and commitment in service to developing NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Before being named Chief Scientific Officer in January of 2021, she was chair of the NCCN Guidelines® Panel for Survivorship (a role previously held by Dr. Carlson)…
PR Newswire
23/08/2023

ClariMed Announces Appointment of New Chief Financial Officer

"Xin is passionate about being part of an operating team," said Kelley Kendle, CEO of ClariMed. "His experience, vision, and enthusiasm about joining our team and building something meaningful together make him the perfect fit for our organization as we continue to grow, expand our investments, and reaffirm our dedication to strategic acquisitions." "Xin is passionate about being part of an operating team," saidKelley Kendle, CEO of ClariMed. "His experience…
PR Newswire
23/08/2023

Unither Pharmaceuticals has completed the purchase of the Novartis site located…

Unither Pharmaceuticals has a major interest in the fast-growing ophthalmology market. Thus, ongoing investments are being made, including the acquisition of this new plant in Latin America, which allows the company to manufacture ophthalmic healthcare products across four continents (Europe, Asia, North America, and South America). Unither Pharmaceuticals has a major interest in the fast-growing ophthalmology market. Thus, ongoing investments are being made, including the acquisition of this...
PR Newswire
23/08/2023

Tiziana Life Sciences Announces Foralumab Presentation by Dr. Howard Weiner at…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced an oral presentation of “Nasal anti-CD3 mAb induces Tregs that dampen microglial activation and treat neuroinflammatory diseases including MS, AD and ALS” at the 16 thInternational Society of Neuroimmunology (ISNI) Congress in Quebec City, Canada, being held August 21-24, 2023. Dr. Weiner's live presentation is scheduled for 11:42...
Nasdaq GlobeNewswire
23/08/2023

Heart Pump Device Market To Reach $11.28 Billion By 2030: Grand View Research…

Read 120-page market research report, "Heart Pump Device Market Size, Share & Trends Analysis Report By Type, By Product (Ventricular Assist Devices, Total Artificial Hearts), By End-use (Hospital, Cardiac Centers), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 120-page market research report,"Heart Pump Device Market Size, Share & Trends Analysis Report By Type, By Product (Ventricular Assist Devices, Total Artificial Hearts), By…
PR Newswire
23/08/2023

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the…

The first case was performed in an 84-year-old woman with severe symptomatic tricuspid regurgitation (TR) at Piedmont Heart Institute through the right internal jugular vein. The TR level was reduced from severe to none and the patient was discharged from the hospital within two days after the procedure. According to Pradeep Yadav, MD, James Stewart, MD, and Vinod Thourani, MD of the Piedmont Heart Institute who conducted the first case "This marks a major milestone in the management of TR…
PR Newswire
23/08/2023

Cleaning Services Market to be Worth $616.98 Billion by 2030: Grand View…

Read full market research report with ToC, "Cleaning Services Market Size, Share & Trends Analysis Report By Type (Window Cleaning, Vacuuming, Floor Care), By End-use (Residential, Commercial Spaces), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report with ToC, " Cleaning Services Market Size, Share & Trends Analysis Report By Type (Window Cleaning, Vacuuming,Floor Care ), By End-use (Residential, Commercial…
PR Newswire
23/08/2023

BioArctic receives patent in Japan for new antibodies targeting Parkinson's…

At the International Congress of Parkinson's disease and movement disorders® (MDS) in September 2021, results presented from the Phase 1 study with BAN0805 supported continued development of the antibody in Phase 2 with once-monthly dosing. At the International Congress of Parkinson's disease and movement disorders® (MDS) inSeptember 2021, results presented from the Phase 1 study with BAN0805 supported continued development of the antibody in Phase 2 with once-monthly dosing. "I am...
PR Newswire
23/08/2023

Maypharm Launches the world first Adipose Stem Cell Exosome hair filler, HAIRNA…

Alopecia and other hair anomalies can happen due to an array of causes, the most common being: Alopecia and other hair anomalies can happen due to an array of causes, the most common being: 1. Loss of collagen in hair follicles due to aging 2. Loss of capillaries in the scalp, cutting oxygen and nutrient supply to the follicles 3. Decrease in follicle size and increased oil production due to DHT hormone expression 4. Reduced scalp regeneration and healing capacity due to...
PR Newswire
23/08/2023

Hearing loss company Acousia Therapeutics to present key learnings and data from…

On September 2, the company has been invited to present the talk "ACOU085 – Lessons Learned from Developing a Locally Administered Otoprotectant" at the 2023 Hearing Therapeutics Summit organized by the Royal National Institute for Deaf People (RNID), University College London Ear Institute, and National Institute for Health and Care Research in London. OnSeptember 2, the company has been invited to present the talk"ACOU085 – Lessons Learned from Developing a Locally…
PR Newswire
23/08/2023

Nexstim Delivers an NBS 5+ System to a New Customer for Neuroscience Use

Press release, Helsinki, 23 August 2023 at 10 AM (EEST) Nexstim Delivers an NBS 5+ System to a New Customer for Neuroscience Use Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order and delivered an NBS 5+ system to an established hospital specializing in psychiatric care in the United States.The NBS 5+ system combines the capabilities of Nexstim's NBS (Navigated Brain Stimulation) and NBT® (Navigated Brain Therapy) systems that are both based on…
Nasdaq GlobeNewswire
23/08/2023

Invitation to presentation of Sectra's three-month interim report 2023/2024

To participate, follow the instructions on Sectra's website investor.sectra.com/q1report2324. The broadcast will be made available on the same webpage after the conference. To participate, follow the instructions on Sectra's websiteinvestor.sectra.com/q1report2324. The broadcast will be made available on the same webpage after the conference. Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to...
PR Newswire
23/08/2023

Devyser Diagnostics AB publishes quarterly report for the period April to June…

The period from January to June 2023 The period from January toJune 2023 Important events during the quarter Devyser launches first IVDR-certified productIn March, Devyser launched Compact, the company's first IVDR-certified product. This is a rapid genetic test for the diagnosis of fetal chromosomal abnormalities, and is the first in its field to be approved in accordance with the IVDR, the new, more comprehensive, European regulatory framework that came into force inMay 2022...
PR Newswire
23/08/2023

Neoss® Group Signs Agreement with Apex-Material e Equipamento Médico, Lda for…

"Together with Apex-Material e Equipamento Médico, we can deliver the highest standard of dental implant treatments and ensure optimal patient outcomes. Apex will be a great partner for us to launch our products in Portugal." - Dr. Robert Gottlander, CEO and President of Neoss Group. "Together with Apex-Material e Equipamento Médico, we can deliver the highest standard of dental implant treatments and ensure optimal patient outcomes. Apex will be a great partner for us to launch…
PR Newswire
23/08/2023

Bavarian Nordic Announces First Half 2023 Results

COPENHAGEN, Denmark, August 23, 2023– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2023 and released its financial calendar for 2024. Revenue increased by 278% to DKK 3,239 million for the first half and the operating profit (EBITDA) increased to DKK 1,171 million.For the first half, revenue comprised of DKK 2,182 million from sale of JYNNEOS ® /IMVANEX ® /IMVAMUNE ®mpox/smallpox vaccine, DKK 555 million from...
Nasdaq GlobeNewswire
23/08/2023

Vistin Pharma ASA: Second quarter and first half 2023 financial results

rdof August 2023Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter and first half of 2023.Revenue in the second quarter ended at MNOK 107 compared to MNOK 69 in Q2 2022. Increased volume from the new production line compared to the same quarter last year has resulted in more volumes available for sale. Revenue for first half of 2023 ended at MNOK 208 compared to MNOK 102 YTD last year, a 103% increase.Second quarter EBITDA ended...
Nasdaq GlobeNewswire
23/08/2023

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III…

SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators. We are continuing the study until the final analysis for overall survival. All other studies in the tiragolumab programme will continue as planned.The interim results for the primary endpoint of overall survival were not mature at the time of the second interim analysis, with median overall survival estimates of 22.9 months [95% CI: 17.5, NE] in the tiragolumab plus Tecentriq arm, and 16.7 months [95%...
Nasdaq GlobeNewswire
23/08/2023

Sleep Aid Global Market to Surpass USD 50 Billion Mark by 2028 | DelveInsight

Key Takeaways from the Sleep Aid Market Report Key Takeaways from the Sleep Aid Market Report To read more about the latest highlights related to the sleep aid market, get a snapshot of the key highlights entailed in theGlobal Sleep Aid Market Report Sleep Aid Overview Sleep aids are substances or techniques designed to help individuals attain restful and rejuvenating sleep. These aids encompass a range of options, from over-the-counter supplements and prescription...
PR Newswire
22/08/2023

Sobi resolves on a rights issue of approximately SEK 6,024 million

The rights issue in brief[1] The rights issue in brief [1] Background and reasons for the rights issue On10 May 2023, Sobi announced that the Company had entered into an agreement, under which Sobi agreed to submit a cash tender offer for all the shares in CTI for a purchase price ofUSD 1,684 million(corresponding toSEK 18,060 million[2] ). The acquisition was completed on26 June 2023after successful completion of the tender offer. CTI is a U.S. commercial-stage...
PR Newswire
22/08/2023

Virbac launches a share buyback program

Following the decision of the board of directors on June 19, 2023 and its approval by the shareholder's meeting, we are going to buy back 100,000 of our own shares (less than 1.25% of the capital). Main objective: to decrease the company's share capital by canceling treasury shares purchased. Description of the 2023-2024 share buyback program In accordance with the provisions of article 5 of regulation (EU) n°. 596/2014, article 2 of delegated regulation (EU) 2016/1052 and...
Nasdaq GlobeNewswire
22/08/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2023

Aggregatedpresentationbydayandbymarket Name of issuerIdentificationcodeof issuer (Legal Entity Identifier)Day of transactionIdentificationcodeof financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *Market (MIC Code) IPSEN549300M6SGDPB4Z94P1114/08/2023FR001025915057122.20AQEUIPSEN549300M6SGDPB4Z94P1114/08/2023FR00102591501,543122.09XPAR...
Nasdaq GlobeNewswire
22/08/2023

Analysis Of The Healthcare Services Industry 2023-2032, By The Global Market…

The global healthcare providers and services industry draws strength from substantial technological advancements that render services more affordable, a rise in medical tourism, rapid population expansion, elevated per-capita income, robust healthcare expenditure in developed nations, government initiatives, and a high prevalence of diseases such as Alzheimer's and Parkinson's among the elderly population on a global scale. The global healthcare providers and services industry draws strength...
PR Newswire
22/08/2023
Altri  Comunicati